Prosecution Insights
Last updated: April 19, 2026

Examiner: BENZION, GARY

Tech Center 1600 • Art Units: 1600 1634 1637 1681

This examiner grants 17% of resolved cases

Performance Statistics

16.9%
Allow Rate
-43.1% vs TC avg
98
Total Applications
+13.5%
Interview Lift
1102
Avg Prosecution Days
Based on 89 resolved cases, 2023–2026

Rejection Statute Breakdown

6.9%
§101 Eligibility
19.0%
§102 Novelty
32.9%
§103 Obviousness
27.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18511481 METHODS FOR SPATIAL ANALYSIS USING ROLLING CIRCLE AMPLIFICATION AND DETECTION PROBES Non-Final OA 10x Genomics, Inc.
18556049 USE OF MUTATIONAL SIGNATURES FOR MULTIPLE CANCER TYPES Non-Final OA UNM Rainforest Innovations
17914142 COMPOSITION FOR CILIOGENESIS PROMOTION, CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELL OR MESENCHYMAL STEM CELL CULTURE SOLUTION Non-Final OA SAMSUNG LIFE PUBLIC WELFARE FOUNDATION.
18743117 GENES FOR REGULATING SPIKE-BRANCHED IN WHEAT AND APPLICATION THEREOF Non-Final OA Yulin University
18608644 TRANSGENIC BANANA PLANTS HAVING INCREASED RESISTANCE TO FUSARIUM OXYSPORUM TROPICAL RACE 4 AND METHODS OF PRODUCING SAME Non-Final OA Elo Life Systems
17791785 COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES Non-Final OA The Sallie Astor Burdine Breast Foundation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month